The CPT Editorial Panel’s February and May 2026 Summary of Actions offers an early look at where coding and reimbursement are headed, and ophthalmology is clearly part of the conversation.

In this episode, our consultants break down the ophthalmology-related proposals, accepted actions, withdrawn items, and emerging Category III codes discussed by the CPT Panel. Topics include adult goniotomy coding changes, intraocular drug delivery implants, subretinal prostheses, intracapsular magnification devices, minimally invasive glaucoma procedures, and evolving crosslinking HCPCS reporting.

The discussion also explores why Category III codes matter, how CPT Panel actions influence future reimbursement pathways, and what ophthalmology practices should be watching now to prepare for future operational and documentation changes.

In Part 3 of our ASCRS 2026 series, we explore photobiomodulation and its potential role in advancing eye care. We’re joined by Traci Brackett and Joshua Anderson from Alcon, who share their insights on this emerging therapy, how it works, and where it may fit into clinical practice. From innovation to real-world application, this conversation highlights what providers should know as new technologies continue to shape the future of patient care.

Contact us by calling (800) 399-6565 or visiting CorcoranCCG.

In Part 2 of our ASCRS 2026 coverage, we dive into iDose TR and the evolution of interventional glaucoma. Joined by Tom Powell and Cynthia Pointer from Glaukos, we explore what these innovations mean in practice, how they’re changing treatment approaches, and what providers should be paying attention to moving forward.

Contact us by calling (800) 399-6565 or visiting CorcoranCCG.

This is Part 1 of our ASCRS series.  In this episode, we are sharing key highlights and emerging trends discussed at the recent ASCRS/ASOA meeting in Washington, DC. We’re joined by Anish Kapur, who offers his perspective on what’s shaping the industry—grounded in his work with Promptly, a patient engagement platform focused on streamlining payments, collections, and patient communication through automation and AI.

As a follow up to our last podcast addressing correct billing for injectable medications, this session focuses specifically on recent changes to coverage polices for Botulinum toxin injections. Recent instructions on coverage, frequency, sharing vials and documentation will require practices to rethink their process and pay closer attention to charting.

Drug billing continues to be a high-risk area for ophthalmology practices. In this episode, Mary Pat Johnson and Rebecca Greenlaw discuss key considerations related to ophthalmology J-codes, including modifier use, dosing accuracy, Medicare reimbursement, and how drug billing decisions can affect performance under MIPS. This practical conversation is designed to help practices reduce audit risk and strengthen compliance.

In our latest episode of Ophthalmology Reimbursed, we talk about pearls from our What’s New in 2026 & How Can You Prepare for the Changes?  webinar series that highlight key Medicare updates for ophthalmology practices, including an increase in ASC rates, the introduction of two conversion factors now used in calculating Medicare allowed amounts for physician services and the reduction to practice expense RVUs for many services provided in facilities. These changes reinforce the need for practices to understand payment changes coming and how to prepare for 2026.

Get ready for a fast-moving, expert-level discussion on the compliance pressures facing ophthalmology practices right now. In this episode, our consultants break down what the government reopening means for held claims, the latest RAC audit topics targeting providers, how TPE reviews are evolving, and the rules behind how often comprehensive versus intermediate eye codes can be billed. Packed with practical guidance and red-flag insights, this episode is a must-listen for any practice focused on staying compliant, reducing denials, and protecting revenue.

2026 may be anything but “business as usual”.

The time to prepare is now. Join one of our live webinars to learn more about the proposed 2026 updates, how they’ll affect your practice and strategies to consider to help offset the decreases in reimbursement.

As 2025 winds down, Mary Pat Johnson and Rebecca Greenlaw unpack Humana’s claims reversal and the upcoming MIPS review deadline. They also clarify Medicare participation and opt-out options for ophthalmologists. Tune in for practical insight to keep your practice compliant and prepared for the new year!

Recorded live at American Academy of Ophthalmology in Orlando, Rebecca Greenlaw and Mary Pat Johnson share highlights from the meeting — from exciting new technology to pressing payer issues like Humana denials and downcoding. Hear the latest on reimbursement trends, fee schedule updates, and what to expect heading into 2026.

In this debut episode, Mary Pat Johnson and Rebecca Greenlaw of Corcoran Consulting Group break down the complexities of Modifier 25. From Medicare’s shifting guidance to documentation pitfalls, they discuss when it applies, common mistakes, and best practices. Learn how to distinguish exceptions, strengthen charting, and stay ahead of evolving rules.